PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Original source
here.
Recent news
December 12, 2024
Health IT Business News
Read more
December 12, 2024
“Back to the Future”: Developments in Immunotherapy with David Gandara, MD
Read more
December 6, 2024
In Brief This Week
Read more
December 3, 2024
OncoHost earns CAP accreditation for Cary laboratory
Read more
December 3, 2024
OncoHost Proteomics Lab Earns CAP Accreditation
Read more
November 17, 2024
Bonus Features – November 17, 2024
Read more
Read all news
